Literature DB >> 23394775

Systemic hypertension requiring treatment in the neonatal intensive care unit.

Raj Sahu1, Hariyadarshi Pannu, Robert Yu, Sanjay Shete, John T Bricker, Monesha Gupta-Malhotra.   

Abstract

OBJECTIVES: To determine the difference in the risk factors for systemic hypertension in preterm and term infants in the neonatal intensive care unit (NICU). STUDY
DESIGN: Data were collected from an existing database of NICU children and confirmed by chart review. Systemic hypertension was defined when 3 separate measurements of systolic and/or diastolic blood pressure were >95th percentile and an antihypertensive medication was administered for >2 weeks in the NICU.
RESULTS: Of 4203 infants, we identified 53 (1.3%) with treated hypertension, of whom 74% were preterm, 11% required surgical intervention, and 85% required medications on discharge. The presence of a patent ductus arteriosus, umbilical catheterization, left ventricular hypertrophy, hypertensive medication at discharge, and mortality was similar between the term and preterm infants. The major risk factors for preterm infants, especially those <28 weeks' gestation, were bronchopulmonary dysplasia and iatrogenic factors, but, in term infants, they were systemic diseases. Term infants were diagnosed with hypertension earlier during hospitalization, had a shorter duration of stay in the NICU, and had a higher incidence of hypertension needing >3 medications than preterm infants.
CONCLUSIONS: Perinatal risk factors are significant contributors to infantile hypertension. Term infants were diagnosed with hypertension earlier, had a shorter duration of stay, and had a higher incidence of resistant hypertension than preterm infants.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23394775      PMCID: PMC3675186          DOI: 10.1016/j.jpeds.2012.12.074

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

1.  Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism?

Authors:  Merzaka Lazdam; Arancha de la Horra; Alex Pitcher; Zola Mannie; Jonathan Diesch; Corinne Trevitt; Ilias Kylintireas; Hussain Contractor; Atul Singhal; Alan Lucas; Stefan Neubauer; Rajesh Kharbanda; Nicholas Alp; Brenda Kelly; Paul Leeson
Journal:  Hypertension       Date:  2010-05-17       Impact factor: 10.190

Review 2.  Hypertension in the neonatal period.

Authors:  Joseph T Flynn
Journal:  Curr Opin Pediatr       Date:  2012-04       Impact factor: 2.856

3.  Incidence and treatment of hypertension in the neonatal intensive care unit.

Authors:  Douglas L Blowey; Patti J Duda; Peggy Stokes; Matthew Hall
Journal:  J Am Soc Hypertens       Date:  2011-09-17

4.  Change in blood pressure and pulse pressure in preterm infants after treatment of patent ductus arteriosus with indomethacin.

Authors:  Ui Joung Han; Hwa Jin Cho; Young Kuk Cho; Young Youn Choi; Jae Sook Ma
Journal:  Korean Circ J       Date:  2011-04-30       Impact factor: 3.243

5.  Renovascular hypertension in children.

Authors:  R Estepa; N Gallego; L Orte; E Puras; E Aracil; J Ortuño
Journal:  Scand J Urol Nephrol       Date:  2001-10

6.  Hypertension in the first month of life.

Authors:  K F Buchi; R L Siegler
Journal:  J Hypertens       Date:  1986-10       Impact factor: 4.844

7.  Systemic hypertension in infants with bronchopulmonary dysplasia.

Authors:  S H Abman; B A Warady; G M Lum; B L Koops
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

8.  Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up.

Authors:  A L Friedman; V A Hustead
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

9.  Hypertension screening in the follow-up of premature infants.

Authors:  D N Sheftel; V Hustead; A Friedman
Journal:  Pediatrics       Date:  1983-05       Impact factor: 7.124

10.  Epidemiology and management of severe symptomatic neonatal hypertension.

Authors:  M E Skalina; R M Kliegman; A A Fanaroff
Journal:  Am J Perinatol       Date:  1986-07       Impact factor: 1.862

View more
  13 in total

1.  Essential hypertension vs. secondary hypertension among children.

Authors:  Monesha Gupta-Malhotra; Ashish Banker; Sanjay Shete; Syed Sharukh Hashmi; John E Tyson; Michelle S Barratt; Jacqueline T Hecht; Diane M Milewicz; Eric Boerwinkle
Journal:  Am J Hypertens       Date:  2014-05-18       Impact factor: 2.689

2.  Sodium nitroprusside, a lifesaving treatment for neonatal hypertension: an Irish experience.

Authors:  Alina Gina Deliu; Phani Bhushan Jeerigehalli Sanneerappa; Orla Franklin; Johannes Letshwiti
Journal:  BMJ Case Rep       Date:  2018-03-28

Review 3.  Neonatal hypertension: cases, causes, and clinical approach.

Authors:  Michelle C Starr; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2018-05-28       Impact factor: 3.714

4.  Neonatal hypertension: an educational review.

Authors:  Matthew W Harer; Alison L Kent
Journal:  Pediatr Nephrol       Date:  2018-07-05       Impact factor: 3.714

Review 5.  Systemic Hypertension in Infants with Bronchopulmonary Dysplasia.

Authors:  Michelle C Starr; Amy C Wilson
Journal:  Curr Hypertens Rep       Date:  2022-03-10       Impact factor: 5.369

6.  Characteristics of hypertension in premature infants with and without chronic lung disease: a long-term multi-center study.

Authors:  Randall D Jenkins; Julia K Aziz; Ladawna L Gievers; Harrison M Mooers; Nora Fino; David J Rozansky
Journal:  Pediatr Nephrol       Date:  2017-07-03       Impact factor: 3.714

7.  Characteristics of systemic hypertension in preterm children.

Authors:  Ankur B Shah; S Sharukh Hashmi; Raj Sahulee; Hariyadarshi Pannu; Monesha Gupta-Malhotra
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-16       Impact factor: 3.738

8.  Pulmonary Function and Systolic Blood Pressure in Very Low Birth Weight Infants at 34 - 36 Weeks of Corrected Age.

Authors:  Ladawna L Gievers; Randall D Jenkins; Amy Laird; Marissa C Macedo; Diane Schilling; Cindy T McEvoy
Journal:  Res Rep Neonatol       Date:  2019-09-13

9.  Antenatal exposure to nonsteroidal anti-inflammatory drugs and risk of neonatal hypertension.

Authors:  Mounira Habli; Corey C Clifford; Tammy M Brady; Zahidee Rodriguez; Michaela Eschenbacher; Malcolm Wu; Emily DeFranco; James Gresh; Beena D Kamath-Rayne
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-27       Impact factor: 3.738

10.  Antihypertensive drug exposure in premature infants from 1997 to 2013.

Authors:  Srikanth Ravisankar; Devon Kuehn; Reese H Clark; Rachel G Greenberg; P Brian Smith; Christoph P Hornik
Journal:  Cardiol Young       Date:  2016-10-17       Impact factor: 1.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.